Drugs / RATG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00752479 Background | May 2008 → Jul 2013 | — | Mario Negri Institute for Pharmacological Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00752479 ↗ |
| Route | Intravenous | “Low dose RATG (0.5 mg/kg/day i.v. day 0-6 post-tx).” NCT00752479 ↗ |